Hepatitis Monthly

Published by: Kowsar

Characterization of Occult Hepatitis B Infection Among Injecting Drug Users in Tehran, Iran

Maryam Asli 1 , Tahmineh Kandelouei 2 , Koroush Rahimyan 3 , Foad Davoodbeglou 4 and Maryam Vaezjalali 3 , *
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Microbiology, Faculty of Biological Sciences, Shahid Beheshti University, Tehran, IR Iran
3 Department of Microbiology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Hepatitis Monthly: March 01, 2016, 16 (3); e34763
  • Published Online: March 29, 2016
  • Article Type: Research Article
  • Received: November 16, 2015
  • Revised: February 27, 2016
  • Accepted: March 8, 2016
  • DOI: 10.5812/hepatmon.34763

To Cite: Asli M, Kandelouei T, Rahimyan K, Davoodbeglou F, Vaezjalali M. et al. Characterization of Occult Hepatitis B Infection Among Injecting Drug Users in Tehran, Iran, Hepat Mon. 2016 ;16(3):e34763. doi: 10.5812/hepatmon.34763.

Abstract
Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Ding X, Mizokami M, Ge X, Orito E, Iino S, Ueda R, et al. Different hepatitis B virus genotype distributions among asymptomatic carriers and patients with liver diseases in Nanning, southern China. Hepatol Res. 2002; 22(1): 37-44[PubMed]
  • 2. Fan HB, Guo YB, Zhu YF, Chen AS, Zhou MX, Li Z, et al. Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor beta Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection. Hepat Mon. 2012; 12(5): 333-8[DOI][PubMed]
  • 3. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol. 2009; 83(20): 10538-47[DOI][PubMed]
  • 4. Tran TT, Trinh TN, Abe K. New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol. 2008; 82(11): 5657-63[DOI][PubMed]
  • 5. Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol. 2009; 15(46): 5761-9[PubMed]
  • 6. Kramvis A, Kew MC. Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J Viral Hepat. 2005; 12(5): 456-64[DOI][PubMed]
  • 7. Dokanehiifard S, Bidmeshkipour A. Study of hepatitis b virus (hbv) genotypes in kermanshah province, west of Iran. J Biol Sci. 2009; 1: 113-20
  • 8. Bokharaei-Salim F, Keyvani H, Monavari SH, Esghaei M, Fakhim S, Ataei Pirkooh A, et al. Distribution of hepatitis B virus genotypes in azerbaijani patients with chronic hepatitis B infection. Hepat Mon. 2014; 14(12)[DOI][PubMed]
  • 9. Vaezjalali M, Rezaee R, Goudarzi H. HBV S Gene Premature Stop Codon in Strains From Middle Eastern Patients. Arch Clin Infect Dis. 2013; 8(1): 3-7
  • 10. Hunt CM, McGill JM, Allen MI, Condreay LD. Clinical relevance of hepatitis B viral mutations. Hepatology. 2000; 31(5): 1037-44[DOI][PubMed]
  • 11. Liu CJ, Kao JH, Shau WY, Chen PJ, Lai MY, Chen DS. Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease. J Med Virol. 2002; 68(1): 50-9[DOI][PubMed]
  • 12. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009; 373(9663): 582-92[DOI][PubMed]
  • 13. Vaezjalali M, Norder H, Magnius L, Jazayeri SM, Alavian SM, Mokhtari-Azad T. A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis. J Viral Hepat. 2009; 16(4): 259-64[DOI][PubMed]
  • 14. Azadmanesh K, Mohraz M, Aghakhani A, Edalat R, Jam S, Eslamifar A, et al. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody. Intervirology. 2008; 51(4): 270-4[DOI][PubMed]
  • 15. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med. 1999; 341(1): 22-6[DOI][PubMed]
  • 16. Zuckerman AJ. Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet. 2000; 355(9213): 1382-4[DOI][PubMed]
  • 17. Ackerman Z, Wands JR, Gazitt Y, Brechot C, Kew MC, Shouval D. Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes. J Hepatol. 1994; 20(3): 398-404[PubMed]
  • 18. Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A, et al. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol. 2001; 34(3): 447-54[PubMed]
  • 19. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology. 2001; 34(1): 194-203[DOI][PubMed]
  • 20. Lugoboni F, Quaglio G, Civitelli P, Mezzelani P. Bloodborne viral hepatitis infections among drug users: the role of vaccination. Int J Environ Res Public Health. 2009; 6(1): 400-13[DOI][PubMed]
  • 21. Chen BF, Chen PJ, Jow GM, Sablon E, Liu CJ, Chen DS, et al. High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users. J Med Virol. 2004; 74(4): 536-42[DOI][PubMed]
  • 22. Karimi AP. 483 Seroprevalence of HBV, HCV and HIV among intravenous drug users in Iran. J Clin Virol. 2006; 36
  • 23. Jazayeri SM, Basuni AA, Sran N, Gish R, Cooksley G, Locarnini S, et al. HBV core sequence: definition of genotype-specific variability and correlation with geographical origin. J Viral Hepat. 2004; 11(6): 488-501[DOI][PubMed]
  • 24. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology. 2004; 47(6): 289-309[DOI][PubMed]
  • 25. Daw MA, Shabash A, El-Bouzedi A, Dau AA, Association with the Libyan Study Group of H. Seroprevalence of HBV, HCV & HIV co-infection and risk factors analysis in Tripoli-Libya. PLoS One. 2014; 9(6)[DOI][PubMed]
  • 26. Kandelouei T, Hosseini SM, Gachkar L, Keyvani H, Davoodbeglou F, Vaezjalali M. Reduction in prevalence of hepatitis b surface antigen among intravenous drug users in tehran drop-in-centers. Arch Clin Infect Dis. 2013; 8(2): 1-8
  • 27. Bureau for Psychosocial Health IMoH 2008;
  • 28. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009; 12(3): 225-31[PubMed]
  • 29. Ramezani A, Banifazl M, Eslamifar A, Aghakhani A. Serological pattern of anti-HBc alone infers occult hepatitis B virus infection in high-risk individuals in Iran. J Infect Dev Ctries. 2010; 4(10): 658-61[PubMed]
  • 30. Fabrizi F, Messa PG, Lunghi G, Aucella F, Bisegna S, Mangano S, et al. Occult hepatitis B virus infection in dialysis patients: a multicentre survey. Aliment Pharmacol Ther. 2005; 21(11): 1341-7[DOI][PubMed]
  • 31. Lin CL, Liu CJ, Chen PJ, Lai MY, Chen DS, Kao JH. High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users. J Med Virol. 2007; 79(11): 1674-8[DOI][PubMed]
  • 32. Panessa C, Hill WD, Giles E, Yu A, Harvard S, Butt G, et al. Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia. J Viral Hepat. 2009; 16(1): 64-73[DOI][PubMed]
  • 33. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Mahboudi F, Sabahi F, Adeli A, Noorinayer B, et al. Genotype characterization and phylogenetic analysis of hepatitis B virus isolates from Iranian patients. J Med Virol. 2005; 75(2): 227-34[DOI][PubMed]
  • 34. Vaezjalali M, Alavian S, Jazayeri S, Nategh R, Mahmoodi M, Hajibeigi B, et al. Genotype of Hepatitis B Virus Isolates from Iranian Chronic Carriers of the Virus. Hepat mon. 2008; 8(2): 97-100
  • 35. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Adeli A, Sabahi F, Abachi M, Azizi M, et al. Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran. J Med Virol. 2005; 76(3): 318-26[DOI][PubMed]
  • 36. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Noorinayer B, Derakhshan F, Chiani M, et al. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol Infect. 2008; 14(9): 858-66[DOI][PubMed]
  • 37. Salem F, Aghasadeghi M, Javadi F, Roohvand F, Joolaee M, Bahramali G, et al. Using RFLP-PCR and Direct Sequencing to Determine HBV Genotypes in Intravenous Drug User Prisoners in Tehran Province. Razi J Med Sci. 2010; 17(71): 56-65
  • 38. Shahmoradi S, Somi MH, Norouzi M, Alavian SM, Karimzadeh H, Rahimnia R, et al. HBsAg Mutants Clustered Mainly Outside of" a" Determinant in Chronic Carriers From Azarbayjan Province, Iran. Jundishapur J Microbiol. 2013; 6(6)
  • 39. Norouzi M, Ghorashi S, Abedi F, Nejatizadeh A, Ataei B, Malekzadeh R, et al. Identification of Hepatitis B Virus Surface Antigen (HBsAg) Genotypes and Variations in Chronic Carriers from Isfahan Province, Iran. Iran J Public Health. 2012; 41(3): 104-11[PubMed]
  • 40. Hamkar R, Aghakhani A, Soufian S, Banifazl M, Ghavami N, Nadri M, et al. Surface gene mutations of hepatitis B virus among high-risk patients with occult hepatitis B virus infection. Diagn Microbiol Infect Dis. 2010; 66(3): 285-91[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments